The circle of CLL
Carlo Croce et al.
Venetoclax in combination with ibrutinib: can it control CLL?
FLT3 inhibitors - their role in AML
Venetoclax for multiple myeloma - mechanism of action and next steps
The management of transaminitis in patients receiving idelalisib